Medline Inc (MDLN) lifted full-year organic sales guidance for the third straight quarter to 10%-10.5% while flagging persistent inflation and quality investments that will temper 2027 EBITDA growth.
Medline (MDLN) landed back in focus after third quarter 2026 results and a fresh US$1b buyback plan, pairing higher sales with sharply lower net income and new capital return commitments. Medline’s latest results and the US$1b buyback plan arrived as the share price trades at US$34.09, with a 7 day share price return of 5.31% following a weaker year to date share price return of 16.08% down, which suggests that short term momentum is building even as longer term sentiment remains...
Medline (MDLN) stock jumps as the company posts better-than-expected results for Q3 2026 and announces plans to buy back up to $1B shares. Read more here.
(MDLN) on Wednesday reported third-quarter earnings of $195 million.The Northfield, Illinois-based company said it had net income of 22 cents per share.
The FDA warns of fire and entrapment risks involving Medline beds.
The medical equipment supplier's motorized beds can overheat and cause fires, regulators said in an urgent alert to consumers.
FDA issues early alert on Medline hospital beds after deaths and injuries tied to fire hazards. Read more here.
Medline Inc. faces pressure from private equity overhang and a recent downward revision in FY26 adj. EBITDA guidance. I rate the MDLN stock a hold. Read my full analysis.
Medline EMEA has launched "10 Minutes That Matter" a new campaign exploring the value of time in the operating theatre and how practical solutions can help healthcare professionals make the most of it.
Medline (MDLN) has an average rating of overweight and mean price target of $44.58, according to ana
Medline (MDLN) is drawing investor attention after a recent share price pullback, with the stock down about 7% over the past month and roughly 9% over the past 3 months. Over a longer stretch, the share price return tells a similar story, with Medline down about 22% year to date. This indicates that momentum has been fading as investors reassess both the company’s growth outlook and the risks they are willing to price into the stock. Compare Medline's recent pullback with a curated 35 high...
Medline shares have fallen sharply this year, which puts the spotlight squarely on whether the current US$31.64 price is still aligned with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) intrinsic value estimate available, the central question is how that cash flow outlook lines up with the market’s reset expectations. The stock is down 22.1% year to date, so the market has already repriced Medline and raised fresh questions about what its future cash...
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index’s 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services […]
Newswire.ca Press Release.
During the September 8 episode of Mad Money, Jim Cramer compared Medline Inc. (NASDAQ:MDLN) to Arizona Cardinals rookie running back Jeremiyah Love and highlighted how temporary setbacks create a unique entry window for patient investors. He remarked: For my third running back, let’s bring in some new blood, please. I’m bringing in Medline, the largest […]
Artisan Partners, an investment management company, released its second-quarter 2026 investor commentary for the “Artisan Global Opportunities Strategy”. The letter can be downloaded here. Global equities rebounded sharply during the quarter, with the MSCI ACWI Index returning 15.3% as resilient economic growth, strong corporate earnings, and continued enthusiasm around artificial intelligence supported markets despite persistent inflation, […]
This is the newest page. Registered accounts read further back.